Download: Advanced precision microsampling for COVID-19 research [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Brochure - hemaPEN [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Brochure - hemaPEN (research use only) [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Brochure - hemaPEN (research use only) (Japanese) [PDF]
hemaPENは開発中でプロトタイプデバイスが研究、調査目的のみで供給可能です。このデバイスは医療または診断には使用できません。Class 1血液採取と補完デバイスとしてhemaPENの登録が2019年末に予定されています。
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
The high-precision, safe and reliable powder automation you’ve always wanted
Download: Brochure - LEAP CHRONECT Quantos integrated powder-liquid automation system [PDF]
View full product details
Post-approval efficacy surveillance
Download: Brochure - SARS-CoV-2 serology testing [PDF]
The Synexa assay kit is supplied for research purposes only. Not for therapeutic or diagnostic use.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Brochure - Septa, caps and liners (portfolio and capabilities) [PDF]
Also see: Brochure - Septa, caps and liners (product information and part numbers)
View full product details
Download: Brochure - Septa, caps and liners (product information and part numbers) [PDF]
Also see: Brochure - Septa, caps and liners (portfolio and capabilities)
Also see: Brochure - GC consumables
View full product details
Download: Instructions for use - hemaPEN [PDF]
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Instructions for use - hemaPEN (research use only) [PDF]
Also see: Video - Instructional video for hemaPEN use (research use only)
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Instructions for use - hemaPEN opening tool [PDF]
The opening tool can only be used in conjunction with Trajan’s hemaPEN. The hemaPEN opening tool has been designed to assist in the retrieval of the dried blood spot samples from internal body of hemaPEN.
View full product details
Download: Part Number List - hemaPEN [PDF]
Also see: Product Data Sheet - hemaPEN
Find in table:
| Part number | Part description and detail |
|---|---|
| 498100000 | hemaPEN D300S |
| 498100010 | hemaPEN W300S |
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Part Number List - hemaPEN (research use only) [PDF]
Also see: Product Data Sheet - hemaPEN (research use only)
Find in table:
| Part number | Part description and detail |
|---|---|
| 498100001 | hemaPEN D300S RUO |
| 498100011 | hemaPEN W300S RUO |
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Poster - Blood sampling made easy [PDF]
Author: Australian National Fabrication Facility (ANFF).
View full product details
Download: Product Data Sheet - hemaPEN [PDF]
Also see: Part Number List - hemaPEN
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Product Data Sheet - hemaPEN (research use only) [PDF]
Also see: Part Number List - hemaPEN (research use only)
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Product Specification Sheet - hemaPEN [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Product Specification Sheet - hemaPEN (research use only)[PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Quick guide - hemaPEN [PDF]
Also see: Quick guide translations - hemaPEN
Also see: Instructions for use - hemaPEN
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Quick guide - hemaPEN (research use only) [PDF]
Also see: Instructions for use - hemaPEN use (research use only)
Also see: Video - Instructional video for hemaPEN use (research use only)
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Quick guide translations - hemaPEN [PDF]
Languages:
Also see: Quick guide - hemaPEN
Also see: Instructions for use - hemaPEN
Also see: Video - Instructional video for hemaPEN use
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490.
Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
